Acquisitions - Estimated Fair Value of Net Assets Acquired (Details) - USD ($)	3 Months Ended
	Jun. 30, 2022	Mar. 22, 2022	Mar. 02, 2022
Liabilities Assumed
Goodwill	$ 130,094,000
BioDelivery Sciences International, Inc
Assets Acquired
Cash and cash equivalents		$ 97,362,000
Accounts receivable		55,495,000
Inventory		77,382,000
Prepaid expenses and other current assets		6,125,000
Property and equipment		1,242,000
Operating lease assets		481,000
Intangible assets		435,000,000
Total assets		673,087,000
Liabilities Assumed
Accounts payable		12,000
Accrued expenses		18,115,000
Accrued rebates, returns and discounts		56,261,000
Operating lease liabilities		481,000
Deferred tax liabilities		58,881,000
Total liabilities		133,750,000
Total identifiable net assets acquired		539,337,000
Goodwill		130,094,000
Total consideration transferred		$ 669,431,000
Increase in inventory	14,300,000
Decrease in intangible assets	(10,000,000)
Increase in accrued rebates, returns and discounts	3,916,000
Increase in prepaid expenses and other current assets	888,000
Decrease in accrued expenses	(502,000)
Increase in deferred tax liabilities	356,000
Net offsetting decrease to Goodwill	$ 1,418,000
Increase to inventory			$ 54,700